Literature DB >> 20395391

Therapeutic results of intra-arterial thrombolysis after full-dose intravenous tissue plasminogen activator administration.

D-S Yoo1, Y-D Won, P-W Huh, H-E Shin, K-T Kim, S-G Kang, S-B Lee, K-S Cho.   

Abstract

BACKGROUND AND
PURPOSE: IV administration of tPA is accepted as a standard treatment for acute cerebral ischemia, but the clinical outcomes cannot be guaranteed in patients who are not recanalized after IV-tPA and in those who are not eligible for IV-tPA. In this study, outcomes from groups of patients treated with additional IA thrombolytic therapy with the use or omission of IV-tPA administration were compared.
MATERIALS AND METHODS: IA thrombolytic therapy (thrombolytic agents combined with mechanical intervention) was attempted in those patients who were not eligible for IV-tPA and who showed continuous major vessel occlusion after IV-tPA. Sixty-three patients were divided into 2 groups: a tPA group (n = 29, IA thrombolysis after IV-tPA) and a non-tPA group (n = 34, IA thrombolysis without IV-tPA). These groups were subdivided according to match or mismatch DWI/PWI after MR imaging. Treatment results were compared by recanalization rate, clinical outcome, mortality, and ICH rate.
RESULTS: The recanalization rate was 79.3% in the tPA group and 55.9% in the non-tPA group (χ(2) test, P < .05). Subgroup analysis between DWI/PWI mismatch in the tPA group and DWI/PWI mismatch in the non-tPA group also showed no statistical difference in recanalization rate, favorable clinical outcome, and mortality (χ(2) test, P > .05), but the significant ICH rate was high in the tPA group (χ(2) test, P < .05).
CONCLUSIONS: Additional IA thrombolytic treatment after full-dose IV-tPA administration might be an acceptable treatment option for patients with DWI/PWI mismatch.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20395391      PMCID: PMC7966079          DOI: 10.3174/ajnr.A2084

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  37 in total

Review 1.  Optimal timing of thrombolytic therapy in acute ischaemic stroke.

Authors:  Ken Madden
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 2.  MR imaging of ischemic penumbra.

Authors:  Osamu Abe; Shigeki Aoki; Ichiro Shirouzu; Akira Kunimatsu; Naoto Hayashi; Tomohiko Masumoto; Harushi Mori; Haruyasu Yamada; Makoto Watanabe; Yoshitaka Masutani; Kuni Ohtomo
Journal:  Eur J Radiol       Date:  2003-04       Impact factor: 3.528

3.  Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

Authors:  A Furlan; R Higashida; L Wechsler; M Gent; H Rowley; C Kase; M Pessin; A Ahuja; F Callahan; W M Clark; F Silver; F Rivera
Journal:  JAMA       Date:  1999-12-01       Impact factor: 56.272

4.  Multimodal therapy for the treatment of severe ischemic stroke combining GPIIb/IIIa antagonists and angioplasty after failure of thrombolysis.

Authors:  Alex Abou-Chebl; Christopher T Bajzer; Derk W Krieger; Anthony J Furlan; Jay S Yadav
Journal:  Stroke       Date:  2005-09-22       Impact factor: 7.914

5.  Thresholds in cerebral ischemia - the ischemic penumbra.

Authors:  J Astrup; B K Siesjö; L Symon
Journal:  Stroke       Date:  1981 Nov-Dec       Impact factor: 7.914

Review 6.  Thrombolytic therapy within 3 to 6 hours after onset of ischemic stroke: useful or harmful?

Authors:  P A Ringleb; P D Schellinger; C Schranz; W Hacke
Journal:  Stroke       Date:  2002-05       Impact factor: 7.914

7.  Local intraarterial urokinase thrombolysis of acute ischemic stroke with or without intravenous abciximab: a pilot study.

Authors:  Deok Hee Lee; Kwang Deog Jo; Hyeon Gak Kim; Soo-Jung Choi; Seung Mun Jung; Dae Sik Ryu; Man Soo Park
Journal:  J Vasc Interv Radiol       Date:  2002-08       Impact factor: 3.464

8.  Comparison of intravenous alteplase with a combined intravenous-endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study.

Authors:  Mikael Mazighi; Jean-Michel Serfaty; Julien Labreuche; Jean-Pierre Laissy; Elena Meseguer; Philippa C Lavallée; Lucie Cabrejo; Tarik Slaoui; Céline Guidoux; Bertrand Lapergue; Isabelle F Klein; Jean-Marc Olivot; Halim Abboud; Olivier Simon; Philippe Niclot; Chantal Nifle; Pierre-Jean Touboul; Gai Raphaeli; Christiane Gohin; Elisabeth Schouman Claeys; Pierre Amarenco
Journal:  Lancet Neurol       Date:  2009-07-31       Impact factor: 44.182

9.  MRI-based and CT-based thrombolytic therapy in acute stroke within and beyond established time windows: an analysis of 1210 patients.

Authors:  Peter D Schellinger; Götz Thomalla; Jens Fiehler; Martin Köhrmann; Carlos A Molina; Tobias Neumann-Haefelin; Marc Ribo; Oliver C Singer; Olivier Zaro-Weber; Jan Sobesky
Journal:  Stroke       Date:  2007-08-16       Impact factor: 7.914

10.  Early functional recovery and the fate of the diffusion/perfusion mismatch in patients with proximal middle cerebral artery occlusion.

Authors:  Oliver C Singer; Richard Du Mesnil De Rochemont; Christian Foerch; Astrid Stengel; Matthias Sitzer; Heiner Lanfermann; Tobias Neumann-Haefelin
Journal:  Cerebrovasc Dis       Date:  2003-10-03       Impact factor: 2.762

View more
  3 in total

1.  A suction thrombectomy technique: a rapid and effective method for intra-arterial thrombolysis.

Authors:  Hyun Park
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2015-03-31

2.  Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in early focal cerebral infarction following urokinase thrombolysis in rats.

Authors:  Yuqiang Song; Hongli Zou; Guofeng Wang; Hongxia Yang; Zhaohong Xie; Jianzhong Bi
Journal:  Neural Regen Res       Date:  2012-06-15       Impact factor: 5.135

3.  Clinical Results of the Intra-Arterial Thrombolysis with Stent Retriever Device Weather Perfusion Diffusion Mismatching and Intravenous Tissue Plasminogen Activator Administration.

Authors:  Young-Jin Kim; Kwang-Wook Cho; Seong-Rim Kim; Do-Sung Yoo; Hae-Kwan Park; Cheol Ji
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2017-12-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.